US Physical Therapy Inc (USPH) (Q3 2026) Earnings Call Highlights: Record Visits
US Physical Therapy Inc (USPH) reported Q3 2026 revenue growth of 13% to $223M, driven by record patient visits and hospital affiliations. Net rate per visit hit $112, and EBITDA grew over 16%. The company reaffirmed full-year EBITDA guidance of $102M-$106M but faced higher self-insured group health costs and increased interest expenses. Management expects continued growth from hospital partnerships and cautious about medical cost trends.
How this was made
The 30-second read
Why it matters
The earnings release provides fresh data on revenue growth, margin pressures, and future partnership rollout, offering traders actionable insight.
Market read
First‑time earnings disclosure with material numbers; relevant for healthcare sector and USPH investors.
What to watch
Potential upside from upcoming full‑quarter hospital partnership ramp‑up in Q4.
Background
US Physical Therapy Inc reported Q3 2026 results, highlighting record patient visits and reaffirmed FY EBITDA guidance.
Ticker impact
Q3 2026 earnings released with record visits, 13% revenue growth to $223M and reaffirmed FY EBITDA guidance of $102-106M.
likely modest downside as investors digest margin headwinds despite top‑line growth
Strong top‑line and guidance reaffirmation support price, but 150 bps margin hit and higher claims expense raise concerns.
Market effects
Physical therapy and outpatient rehab sector may see increased investor interest in hospital affiliation models.
U.S. healthcare services segment could experience modest re‑rating.
Limited to U.S. healthcare equities.
Counterpoint
Margin compression could lead to a sell‑off despite revenue beat.
Key entities
- ExecutiveChris Redding
Chairman and CEO, provided commentary on earnings and partnership outlook.
- ExecutiveChacha Etta
CFO, discussed financial results and cost mitigation actions.
